Fund Finance, NAV & GP Liquidity

Financing GP-Led Secondary Transactions

Financing GP-Led Secondary Transactions is a fund-level liquidity question built around asset value, rollover equity and liquidity needs for the GP led secondary financing case. The debt sits above or alongside portfolio investments, so lender analysis starts with value that can actually reach the borrowing entity for the GP led secondary financing case.

For private equity sponsors, the central underwriting test is debt-to-equity at continuation vehicle in the GP led secondary financing structure. Reported NAV or committed capital matters only after lender eligibility, existing leverage, concentration and distribution mechanics are applied in the GP led secondary financing structure.

Related Financely coverage on how family offices can use nav loans to access liquidity and preferred equity redemption acquisitions provides useful context for the fund-level capital structure when assessing GP led secondary financing.

What the lender is actually underwriting before closing GP led secondary financing

Execution of GP led secondary financing improves when the data room mirrors the lender's credit questions. Documents should be grouped around ownership, historical performance, asset or portfolio value, existing debt, cash control and the repayment source in the GP led secondary financing structure.

That organization lets a credit team verify asset value, rollover equity and liquidity needs without reconstructing the transaction from unrelated files for GP led secondary financing underwriting. It also exposes misalignment between selling fund and new vehicle economics early enough to solve the issue before formal approval for GP led secondary financing underwriting.

Fund-level data that needs to reconcile under the GP led secondary financing downside case

In GP led secondary financing, this section should be read through asset value, rollover equity and liquidity needs. The relevant question for private equity sponsors is which cash flow, commitment or asset right remains available after senior claims and structural restrictions when assessing GP led secondary financing.

A lender will not rely on a headline value if the path to cash is uncertain within the GP led secondary financing transaction. The analysis should therefore reconcile the economic value to debt-to-equity at continuation vehicle and identify exactly where misalignment between selling fund and new vehicle economics could reduce debt capacity within the GP led secondary financing transaction.

Primary sizing metricdebt-to-equity at continuation vehicleUnderwriting focusasset value, rollover equity and liquidity needsDownside riskmisalignment between selling fund and new vehicle economics

Portfolio company debt and value leakage during lender review of GP led secondary financing

The evidence supporting GP led secondary financing needs to be organized at the level where the lender takes risk. That means source documents, historical cash movements and contractual rights should reconcile to the assumptions used for asset value, rollover equity and liquidity needs during the GP led secondary financing review.

Any adjustment that changes debt-to-equity at continuation vehicle materially should be visible in the underwriting bridge for the GP led secondary financing case. This avoids burying misalignment between selling fund and new vehicle economics inside a general contingency or an unsupported management forecast for the GP led secondary financing case.

Concentration tests that can reduce availability after GP led secondary financing is funded

Debt sizing for GP led secondary financing should start from a conservative base case and then test the operating variable most likely to impair repayment. The model should separate permanent value from cash that is timing-dependent for GP led secondary financing underwriting.

For this transaction, debt-to-equity at continuation vehicle is more useful than a gross asset or revenue number because it links proceeds to lender protection in the GP led secondary financing structure. The downside case should explicitly show the effect if misalignment between selling fund and new vehicle economics in the GP led secondary financing structure.

Stress cases around delayed exits for GP led secondary financing

Structure matters in GP led secondary financing because control over cash often changes before the lender experiences an economic loss. Account control, mandatory prepayment, eligibility rules or distribution restrictions can preserve value before enforcement is necessary within the GP led secondary financing transaction.

The documents should translate asset value, rollover equity and liquidity needs into objective tests when assessing GP led secondary financing. When debt-to-equity at continuation vehicle moves outside the agreed range, the lender needs a defined response instead of relying on discretion after misalignment between selling fund and new vehicle economics becomes visible when assessing GP led secondary financing.

Reporting after closing in a GP led secondary financing structure

Concentration needs separate treatment in GP led secondary financing. A diversified pool can absorb one weak asset or counterparty, while a concentrated structure may lose a large share of coverage from a single adverse event for the GP led secondary financing case.

For private equity sponsors, the concentration schedule should sit beside debt-to-equity at continuation vehicle so management can see how proceeds change when one position is excluded or haircut during the GP led secondary financing review. That exercise is especially important where misalignment between selling fund and new vehicle economics during the GP led secondary financing review.

• For GP led secondary financing, reconcile the fund or sponsor entity that will borrow.
• For GP led secondary financing, document the valuation or eligible commitment methodology supporting debt-to-equity at continuation vehicle.
• For GP led secondary financing, map portfolio-company, fund-level and sponsor-level debt before calculating proceeds.
• For GP led secondary financing, identify how misalignment between selling fund and new vehicle economics changes lender coverage and required prepayment.

Execution note for GP led secondary financing

The working file for GP led secondary financing should preserve source data, calculation definitions and the assumptions behind debt-to-equity at continuation vehicle so a lender can reproduce the credit conclusion without relying on management commentary.

What makes the mandate lender-ready when underwriting GP led secondary financing

Maturity for GP led secondary financing should follow the realistic conversion of asset value, rollover equity and liquidity needs into cash. A facility can be well collateralized and still become difficult to refinance if its contractual maturity arrives before the expected realization or collection cycle in the GP led secondary financing structure.

The base case should therefore include a repayment calendar tied to debt-to-equity at continuation vehicle, plus an extension or amortization case that remains workable if misalignment between selling fund and new vehicle economics delays the expected takeout for GP led secondary financing underwriting.

Structure GP led secondary financing for lender review

Financely can assess GP led secondary financing, structure the financing request and run an institutional debt-placement process for qualified private equity sponsors.

Discuss Fund-Level Private Credit